instock
Approved
Tirzepatide 15mg
Body Composition · Lyophilized powder · Stored at 2–8°C
Dual GIP / GLP-1 receptor agonist. EU-authorized for type-2 diabetes and chronic weight management. Each vial contains 15mg of lyophilized Tirzepatide. EU-authorized compound.
SKU
KP-TIRZEPATIDE-15MG
FORM
Lyophilized
STORAGE
2–8°C
€49,00
VAT included · Free EU shipping over €150
Same-day dispatch on orders before 14:00 CET
Cold-chain shipping with phase-change gel packs
Every batch ships with downloadable Certificate of Analysis
Product details
Mechanism, specs and shipping
What it is
Dual GIP / GLP-1 receptor agonist. EU-authorized for type-2 diabetes and chronic weight management.
Mechanism
Tirzepatide is the first dual GIP/GLP-1 receptor agonist, activating both incretin pathways to enhance glucose-dependent insulin secretion, suppress glucagon and slow gastric emptying.
Specifications
- Dosage: 15mg / vial
- HPLC purity: ≥99.2%
- Form: Lyophilized powder
- Storage: 2–8°C, protected from light
- Shipping: Cold-chain dispatch from EU warehouse, same-day if ordered before 14:00 CET
Certificate of Analysis
Every batch ships with a downloadable Certificate of Analysis showing HPLC purity, mass-spec identity confirmation, and microbial/endotoxin pass results.
Related compounds
